165 related articles for article (PubMed ID: 38505614)
1. Depletion of ApoA5 aggravates spontaneous and diet-induced nonalcoholic fatty liver disease by reducing hepatic NR1D1 in hamsters.
Guo J; Miao G; Zhang W; Shi H; Lai P; Xu Y; Zhang L; Chen G; Han Y; Zhao Y; Liu G; Zhang L; Wang Y; Huang W; Xian X
Theranostics; 2024; 14(5):2036-2057. PubMed ID: 38505614
[No Abstract] [Full Text] [Related]
2. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
[TBL] [Abstract][Full Text] [Related]
3. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway.
Li R; Zhu W; Huang P; Yang Y; Luo F; Dai W; Shen L; Pei W; Huang X
Biomed Pharmacother; 2021 Sep; 141():111803. PubMed ID: 34146854
[TBL] [Abstract][Full Text] [Related]
5. Deletion of exons 3 and 4 in the mouse Nr1d1 gene worsens high-fat diet-induced hepatic steatosis.
Na H; Lee H; Lee MH; Lim HJ; Kim HJ; Jeon Y; Kang HL; Lee MO
Life Sci; 2016 Dec; 166():13-19. PubMed ID: 27720799
[TBL] [Abstract][Full Text] [Related]
6. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.
Falkevall A; Mehlem A; Folestad E; Ning FC; Osorio-Conles Ó; Radmann R; de Hollanda A; Wright SD; Scotney P; Nash A; Eriksson U
J Hepatol; 2023 May; 78(5):901-913. PubMed ID: 36717026
[TBL] [Abstract][Full Text] [Related]
8. Dietary Supplementation with Hazelnut Oil Reduces Serum Hyperlipidemia and Ameliorates the Progression of Nonalcoholic Fatty Liver Disease in Hamsters Fed a High-Cholesterol Diet.
Lu JH; Hsia K; Lin CH; Chen CC; Yang HY; Lin MH
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31540081
[No Abstract] [Full Text] [Related]
9. Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters.
Lai YS; Yang TC; Chang PY; Chang SF; Ho SL; Chen HL; Lu SC
J Nutr Biochem; 2016 Apr; 30():44-52. PubMed ID: 27012620
[TBL] [Abstract][Full Text] [Related]
10. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
11. Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model.
Lee SB; Kim HG; Lee JS; Kim WY; Lee MM; Kim YH; Lee JO; Kim HS; Son CG
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G811-G823. PubMed ID: 31604029
[TBL] [Abstract][Full Text] [Related]
12. Comparison of protective effects of hesperetin and pectolinarigenin on high-fat diet-induced hyperlipidemia and hepatic steatosis in Golden Syrian hamsters.
Shi L; Zou M; Zhou X; Wang S; Meng W; Lan Z
Exp Anim; 2023 Feb; 72(1):123-131. PubMed ID: 36310057
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake.
van den Berg SA; Heemskerk MM; Geerling JJ; van Klinken JB; Schaap FG; Bijland S; Berbée JF; van Harmelen VJ; Pronk AC; Schreurs M; Havekes LM; Rensen PC; van Dijk KW
FASEB J; 2013 Aug; 27(8):3354-62. PubMed ID: 23650188
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
15. URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice.
Tanaka Y; Nagoshi T; Takahashi H; Oi Y; Yoshii A; Kimura H; Ito K; Kashiwagi Y; Tanaka TD; Yoshimura M
Mol Metab; 2022 Jan; 55():101411. PubMed ID: 34863940
[TBL] [Abstract][Full Text] [Related]
16. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
[TBL] [Abstract][Full Text] [Related]
17. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.
Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY
J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A5 controls fructose-induced metabolic dysregulation in mice.
Ress C; Dobner J; Rufinatscha K; Staels B; Hofer M; Folie S; Radlinger B; Adolph TE; Rubin EM; Roden M; Tilg H; Kaser S
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):972-978. PubMed ID: 33549451
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism.
Forte TM; Ryan RO
Curr Drug Targets; 2015; 16(12):1274-80. PubMed ID: 26028042
[TBL] [Abstract][Full Text] [Related]
20. Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency.
Maria Del Bas J; Rodríguez B; Puiggròs F; Mariné S; Rodríguez MA; Moriña D; Armengol L; Caimari A; Arola L
Clin Sci (Lond); 2019 Feb; 133(3):409-423. PubMed ID: 29122967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
